Hinge Health, Inc. (HNGE) intrinsic value & 10-year financials
Hinge Health, Inc. (HNGE) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue grew 41.7% a year to $587.9M, with an average return on invested capital of 61.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $99.16
- Market cap
- $5.4B
- Revenue (FY2025)
- $587.9M
- Revenue growth (4-yr CAGR)
- 41.7%
- ROIC (10-yr avg)
- 61.5%
- Free cash flow (FY2025)
- $170.7M
HNGE 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $587.9M | -$528.3M | -$7.77 | $170.7M | -92.9% | 145.0% |
| FY2024 | $390.4M | -$11.9M | -$0.22 | $48.0M | -8.2% | 4.4% |
| FY2023 | $292.7M | -$108.1M | -$2.08 | -$65.9M | -44.6% | 35.0% |
| FY2022 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Hinge Health, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Hinge Health, Inc. has earned high returns on invested capital, averaging 74.7% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Hinge Health, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Hinge Health, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-258.09 per share.